Peripheral blood transcriptome identifies high-risk benign and malignant breast lesions.
Hong HouYali LyuJing JiangMin WangRuirui ZhangChoong-Chin LiewBinggao WangChangming ChengPublished in: PloS one (2020)
A promising method for the detection of breast lesions is reported. This study also sheds light on breast cancer/immune system interactions, providing clues to new targets for breast cancer immune therapy.